Bifogade filer
Nexstim Plc_Press release_Redeye Growth Day_30052022_FINAL
Kurs
-2,12%
Kalender
| Est. tid* | ||
| 2025-08-15 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-03-28 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2025-03-27 | - | Årsstämma |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2024-08-16 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-02 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2024-03-28 | - | Årsstämma |
| 2024-02-27 | - | Bokslutskommuniké 2023 |
| 2023-08-18 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2023-03-31 | - | Årsstämma |
| 2023-02-27 | - | Bokslutskommuniké 2022 |
| 2022-08-12 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-09 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2022-03-31 | - | Årsstämma |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-08-13 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-17 | - | Split NXTMS 100:1 |
| 2021-04-30 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2021-04-29 | - | Årsstämma |
| 2021-03-01 | - | Extra Bolagsstämma 2021 |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-08-14 | - | Kvartalsrapport 2020-Q2 |
| 2020-04-01 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2019-11-11 | - | Extra Bolagsstämma 2019 |
| 2019-08-16 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-28 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2019-03-25 | - | Årsstämma |
| 2019-03-04 | - | Bokslutskommuniké 2018 |
| 2018-11-26 | - | Split NXTMS 30:1 |
| 2018-11-21 | - | Extra Bolagsstämma 2018 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-03-29 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2018-03-28 | - | Årsstämma |
| 2018-02-28 | - | Bokslutskommuniké 2017 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-03-29 | - | X-dag ordinarie utdelning NXTMS 0.00 SEK |
| 2017-03-28 | - | Årsstämma |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2017-02-17 | - | Extra Bolagsstämma 2017 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-03-31 | - | Årsstämma |
| 2016-02-29 | - | Bokslutskommuniké 2015 |
| 2015-12-22 | - | Extra Bolagsstämma 2015 |
| 2015-08-20 | - | Kvartalsrapport 2015-Q2 |
| 2015-03-31 | - | Årsstämma |
| 2015-02-26 | - | Bokslutskommuniké 2014 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Press release, Helsinki, 30 May 2022 at 11 AM (EEST)
Nexstim to Present at Redeye Growth Day 2022
Nexstim Plc’s (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") CEO Mikko Karvinen will be taking part in Redeye Growth Day 2022 in Stockholm on Thursday 2 June 2022.
A pre-recorded presentation is already available at Nexstim’s event space. An extensive Q&A session will be live broadcasted at the Redeye Growth Day 2022 event space on 2 June at 11:05 CEST (12:05 EEST).
Further information is available on the website www.nexstim.com, or by contacting:
Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com
About Nexstim Plc
Nexstim is a Finnish, globally operating growth-oriented medical technology company. Our mission is to enable personalized and effective diagnostics and therapies for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim’s Therapy Business markets and sells the Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.
Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.
For more information, please visit www.nexstim.com